‹ ›
MYP_147218
← PREVIOUS NEXT → BACK
Basic Information
peptide 4a(derived from RSV fusion protein(497-515))
Antimicrobial
Antiviral
Antiviral ▸ Anti-Pneumovirus ▸ Anti-RSV
Antiviral ▸ Antiviral mechanism ▸ Viral fusion inhibition
not Standard
20 amino acids
-
contains X representing unresolved or non-standard residue
Sequence
EKINQSLXFIRXSDXLLHXV
Physicochemical Analysis
0.00 Da
0.00
0.00
0.00
0.00
0.00
The radar chart summarizes major physicochemical dimensions for quick comparison, while exact numerical values remain listed on the left.
Residue Composition
Amino Acid Composition
Chemical Descriptors
Structural Visualization
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber in the current view mode. Use the buttons to zoom.
2D CHEMICAL STRUCTURE
Drag to move
Drag to move. Use the buttons to zoom.
Experimental Records
RECORD: Rec_0058340 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Acetylation
None
The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling
Bio-Activity Profile
Antimicrobial Antiviral
PaperPubMed PMID: 28137809 PMID28137809 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28137809/
RECORD: Rec_0129239 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
Protein-derived synthetic peptide
32630
Structure & Mods
cyclic peptide architecture [Cyclic]
noncanonical stereochemical modification [Modified]
Acetylation
None
The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling.
Bio-Activity Profile
Antiviral Anti-RSV Fusion inhibition
Respiratory syncytial virus (RSV) | Hep-2 cells
1.82±0.42 μM
EC50
Mammalian: 1 h; Yeast: 30 min; E. coli: >10 h
PaperA Short Double-Stapled Peptide Inhibits Respiratory Syncytial Virus Entry and Spreading. | Gaillard V, Galloux M, Garcin D, Eléouët JF, Le Goffic R, Larcher T, Rameix-Welti MA, Boukadiri A, Héritier J, Segura JM, Baechler E, Arrell M, Mottet-Osman G, Nyanguile O. | Antimicrob Agents Chemother. 2017 Mar 24;61(4):e02241-16. | DOI:10.1128/AAC.02241-16 | PMID:28137809 PMID28137809 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28137809/
RECORD: Rec_0240179 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
cyclic/stapled peptide [Cyclic]
canonical L-amino-acid peptide [L]
Acetylation
None
The 'X' at position 8,12,15,19 indicates S-pentenylalanine, X(8) and X(12), X(15) and X(19) are cross-linked by hydrocarbon stapling
Bio-Activity Profile
Antimicrobial Antiviral
Respiratory syncytial virus (RSV):inhibition of virus infection in Hep-2 cells
1.82±0.42 μM
EC50
PaperPubMed PMID: 28137809 PMID28137809 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28137809/
RECORD: Rec_0277670 VERIFIED: YES
Provenance & Taxonomy
synthetic construct [Synthetic]
32630
Structure & Mods
linear peptide [Linear]
canonical L-amino-acid peptide [L]
unspecified non-canonical residue at 8,12,15,19
Bio-Activity Profile
Antiviral
Respiratory syncytial virus (RSV)
PMID28137809 Evidence URLhttps://pubmed.ncbi.nlm.nih.gov/28137809/